Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Allergy to sodium aurothiomalate |
Causative agent (attribute) |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
|
Sodium aurothiomalate 10mg/0.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
|
Sodium aurothiomalate 20mg/0.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
|
Sodium aurothiomalate 50mg/0.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
|
Gold sodium thiomalate 50mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
|
Product containing precisely sodium aurothiomalate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
|
Product containing sodium aurothiomalate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Adverse reaction to sodium aurothiomalate |
Causative agent (attribute) |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Allergy to sodium aurothiomalate |
Causative agent (attribute) |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing sodium aurothiomalate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 10 milligram/0.5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 10 milligram/0.5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 50 milligram/0.5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 50 milligram/0.5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 20 milligram/0.5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 20 milligram/0.5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Sodium aurothiomalate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing only sodium aurothiomalate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Sodium aurothiomalate 20 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Sodium aurothiomalate 20 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium aurothiomalate |
Inferred relationship |
Some |
1 |